Owens Corning (OC)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	255	647	1,196	1,241	995	-383
Depreciation & Amortization	696	664	508	505	489	473
Loss (Gain) From Sale of Assets	72	72	-191	18	-53	-26
Asset Writedown & Restructuring Costs	492	496	101	122	13	1,007
Loss (Gain) From Sale of Investments	-	-	-	-130	-	-
Stock-Based Compensation	100	93	51	51	50	41
Other Operating Activities	-126	-127	87	-28	27	-71
Change in Accounts Receivable	6	6	-26	-14	-28	-109
Change in Inventory	-43	-43	148	-287	-227	189
Change in Accounts Payable	13	13	-158	363	302	25
Change in Other Net Operating Assets	-8	71	3	-81	-65	-11
Operating Cash Flow	1,819	1,892	1,719	1,760	1,503	1,135
Operating Cash Flow Growth	-4.61%	10.06%	-2.33%	17.10%	32.42%	9.45%
Capital Expenditures	-698	-647	-526	-446	-416	-307
Sale of Property, Plant & Equipment	161	115	194	212	89	52
Cash Acquisitions	-2,857	-2,857	-6	-417	-42	-
Other Investing Activities	-12	-4	-18	28	-8	50
Investing Cash Flow	-3,406	-3,393	-356	-623	-377	-205
Short-Term Debt Issued	-	720	-	-	-	876
Long-Term Debt Issued	-	4,752	-	-	-	297
Total Debt Issued	6,302	5,472	-	-	-	1,173
Short-Term Debt Repaid	-	-720	-	-	-	-895
Long-Term Debt Repaid	-	-3,714	-33	-30	-216	-216
Total Debt Repaid	-4,793	-4,434	-33	-30	-216	-1,111
Net Debt Issued (Repaid)	1,509	1,038	-33	-30	-216	62
Repurchase of Common Stock	-466	-491	-657	-795	-570	-318
Common Dividends Paid	-215	-208	-188	-136	-108	-104
Other Financing Activities	4	-5	1	-13	13	2
Financing Cash Flow	832	334	-877	-974	-881	-358
Foreign Exchange Rate Adjustments	-59	-87	30	-22	-3	-27
Net Cash Flow	-814	-1,254	516	141	242	545
Free Cash Flow	1,121	1,245	1,193	1,314	1,087	828
Free Cash Flow Growth	-19.18%	4.36%	-9.21%	20.88%	31.28%	40.34%
Free Cash Flow Margin	9.76%	11.34%	12.33%	13.46%	12.79%	11.74%
Free Cash Flow Per Share	12.83	14.18	13.11	13.45	10.42	7.62
Cash Interest Paid	226	226	135	123	133	135
Cash Income Tax Paid	423	423	428	319	244	78
Levered Free Cash Flow	649.88	789.75	983.75	1,236	948.88	804.5
Unlevered Free Cash Flow	812.38	922.25	1,031	1,300	1,025	882
Change in Net Working Capital	470	374	38	-71	-19	-130

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q